Upload
anonymous
View
221
Download
3
Embed Size (px)
Citation preview
nature biotechnology volume 26 number 7 july 2008 831
Corrigendum: Large-scale chemical dissection of mitochondrial functionBridget K Wagner, Toshimori Kitami, Tamara J Gilbert, David Peck, Arvind Ramanathan, Stuart L Schreiber, Todd R Golub & Vamsi K MoothaNat. Biotechnol. 26, 343–351 (2008); published online 24 February 2008; corrected after print 8 July 2008
In the version of this article initially published, on p.348, column 2, paragraph 2, line 7, the following sentence was incorrect: “Statins block the synthesis of cholesterol—a precursor to ubiquinone….” It should have read “Statins block the synthesis of mevalonate, a precursor not only of cholesterol but also ubiquinone, ….” The error has been corrected in the HTML and PDF versions of the article.
Corrigendum: Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cellsGabsang Lee, Hyesoo Kim, Yechiel Elkabetz, George Al Shamy, Georgia Panagiotakos, Tiziano Barberi, Viviane Tabar & Lorenz StuderNat. Biotechnol. 25, 1468–1475 (2007); published online 25 November 2007; corrected after print 8 July 2008
In the version of this article initially published, a reference was missing from the first paragraph. A new sentence and the reference (no. 6) have been added: “A recent study characterized neural crest differentiation from cloned bovine blastocysts via a neural rosette intermediate6. Other….” Subsequent references have been renumbered. The corrections have been made in the HTML and PDF versions of the article.
Erratum: Looking forward, looking backAnonymousNat. Biotechnol. 26, 475 (2008); published online May 2008; corrected after print 13 June 2008
In the version of this article initially published, in paragraph 4, the generic name and ligand given for Avastin are incorrect. The correct generic name is bevacizumab and its target is VEGF (vascular endothelial growth factor). The error has been corrected in the HTML and PDF versions of the article.
Erratum: Is personalized medicine finally arriving?Malorye AllisonNat. Biotechnol. 26, 509–517 (2008); published May, 2008; corrected after print 8 July 2008
In the version of this article initially published, Table 1 (pp. 510–511) contained two errors. In the entry for Agendia, the product Mammaprint was described as providing information on chemotherapy options for breast cancer patients. In fact Mammaprint is a prognostic test. In the entry for Genomic Health, the product Oncotype Dx was described as providing information on breast cancer recurrence. Oncotype DX also provides information on the response to chemotherapy. The error has been corrected in the HTML and PDF versions of the article.
corr igenda and errata©
2008
Nat
ure
Pub
lishi
ng G
roup
ht
tp://
ww
w.n
atur
e.co
m/n
atur
ebio
tech
nolo
gy